drugset / Trial / NCT01800877
Optimal VAsopressor titraTION Pilot Randomized Controlled Trial
Completed
120 enrolled
Francois Lamontagne
Canadian Critical Care Trials Group · collabCanadian Institutes of Health Research (CIHR) · collabFonds de la Recherche en Santé du Québec · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this research study is to determine if it is better to give vasopressors to patients to maintain a higher blood pressure target versus a lower blood pressure target. This study is important because the information we find out will help us know how best to administer vasopressors in patients with shock in the ICU.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-12
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dopamine | Small molecule | — | — |
| Subject | Epinephrine | Other / unclassified | — | — |
| Subject | Norepinephrine | Other / unclassified | — | — |
| Subject | Phenylephrine | Small molecule | — | — |
| Subject | Vasopressin | Peptide | — | — |